[Home ] [Archive]    
:: Home :: About Journal :: Registration :: Article Submission :: Contact us :: Site Map ::
:: Volume 10, Issue 3 (September 2018 2018) ::
IJBC 2018, 10(3): 87-91 Back to browse issues page
Efficacy of Rituximab in the Treatment of Plasma Exchange Refractory Thrombotic Thrombocytopenic Purpura
Alireza Sadeghi, Farzaneh Ashrafi, Arman Sourani *
Student Research Committee, School of medicine, Isfahan University of Medical sciences, Isfahan, Iran
Abstract:   (568 Views)
Background: Rituximab can induce a durable remission in plasma exchange refractory thrombotic thrombocytopenic purpura (TTP). Timing of Rituximab infusion in combination with plasma exchange (PE) and long term follow-up for probable side effects of such treatment is still lacking.
Methods: This study was conducted among 10 patients with plasma exchange refractory TTP. According to the study designation, first PE was performed within 36-48 hours after first dose of rituximab.
Results: Eight of ten (80%) patients received 1 course of rituximab. Two of ten (20%) patients received another course of rituximab due to relapse. Repsonse rate (RR) to rituximab in combination with plasma exchange, was 90%. Overall Survival of the patients was 90% and 1 and 5-year relapse free survival rate (RFS) was 90% and 83%, respectively. One of the patients expired due to Systemic Lupus Erythematosus flare up.
Conclusion: According to this study, treatment of refractory TTP with rituximab in combination with PE could be effective.
Iranian Registry of Clinical Trials: IRCT2017012232125N1
Keywords: Rituximab, Thrombotic thrombocytopenic purpura, Plasma exchange, Refractory
Full-Text [PDF 725 kb]   (314 Downloads)    
: Research | Subject: Adults Hematology & Oncology
Received: 2018/04/16 | Accepted: 2018/10/24 | Published: 2018/10/24
* Corresponding Author Address: Department of Hematology-Oncology, Alzahra Teaching Hospital, Isfahan, Iran.
Send email to the article author

Add your comments about this article
Your username or Email:


XML   Persian Abstract   Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Sadeghi A, Ashrafi F, Sourani A. Efficacy of Rituximab in the Treatment of Plasma Exchange Refractory Thrombotic Thrombocytopenic Purpura. IJBC. 2018; 10 (3) :87-91
URL: http://ijbc.ir/article-1-799-en.html

Volume 10, Issue 3 (September 2018 2018) Back to browse issues page
مجله ی خون و سرطان ایران Iranian Journal of Blood and Cancer
Persian site map - English site map - Created in 0.06 seconds with 32 queries by YEKTAWEB 3897